Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

cannabis

  • Home
  •  
  • cannabis



  • Most Read
  • Latest Comments
  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia

    Medicinal cannabis products producer ECS Botanics (ASX: ECS) has struck an exclusive distribution deal with California-based Terphogz LLC, paving the way for the arrival of the famed cannabis strain ‘The Original Z’ (commonly known as Zkittlez) in Australia. This partnership marks a significant milestone in Australia’s burgeoning medicinal cannabis market, allowing patients access to one

    Read More
    Public
  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies

    Pharmaceutical and consumer health company, Bioxyne (ASX: BXN) has become the first manufacturer in Australia to produce cannabis gummies under a Good Manufacturing Practice (GMP) licence. Through its subsidiary, Breathe Life Sciences (BLS), Bioxyne has completed the first commercial run of these pharmaceutical-grade edibles, taking an early position in Australia’s fast-evolving medicinal cannabis market where

    Read More
    Public
  • Melodiol moves to clear debt with $12m asset fire sale
    • News

    Melodiol moves to clear debt with $12m asset fire sale

    In early 2024, Melodiol Global Health (ASX: ME1), formerly known as Creso Pharma, faced scrutiny from the ASX, regarding corporate governance and financial disclosure which led to a major restructure and rebrand, but now the time has come to offload a major asset in an attempt for survival under its mounting debt obligations. Melodiol is

    Read More
    Public
  • Althea to make a splash in the US with new cannabis-based sodas
    • News

    Althea to make a splash in the US with new cannabis-based sodas

    First they started brewing cannabis-infused beer, now Althea Group (ASX: AGH) is bringing cans of cannabis-based sodas to the market that will inevitably have certain consumers checking whether they’re tripping.  The move is set to shake up the cannabis-based products market as a recreational product that will make a bold entry into the burgeoning US

    Read More
    Public
  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products

    Recreational cannabis use has been a global topic for debate in the past few years but cannabinoids, a naturally occurring compound in cannabis, are now gaining momentum as a treatment for managing pain, inflammation and various mental health conditions like depression and PTSD. For the past several months, Melodiol Global Health’s (ASX: ME1) subsidiary, Health

    Read More
    Public
  • Wellnex ventures into medicinal cannabis with it’s new Wellness Life brand
    • News

    Wellnex ventures into medicinal cannabis with it’s new Wellness Life brand

    Seeking expansion into the burgeoning medicinal cannabis market as part of the plant’s trend as a treatment for various common ailments, Wellnex Life (ASX: WNX) will debut its new Wellness Life cannabis brand next month.  The launch of Wellness Life will be supported by a collaboration with OneLife Botanicals and is bolstered by the appointment

    Read More
    Public
  • 1
  • 2
  • 3
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.